A paper just published in Clinical Cancer Research has suggested that — at least for one immunotherapeutic agent (“vaccine”) in development for the treatment of advanced prostate cancer — it may be possible to define a subgroup of men who are more likely to respond well to treatment than others. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: antibody, glycan, microarray, PROSTVAC-VF, serum | 4 Comments »
A decision (or the lack of it) by the US federal government may imperil viability of the Swedish company known as Barvarian Nordic — and the development of Prostvac VF, now in development for treatment of advanced prostate cancer. … READ MORE …
Filed under: Drugs in development | Tagged: Imvamune, PROSTVAC-VF, smallpox | Leave a comment »
According to a story on ScienceDaily today, investigators are continuing to plan for a Phase III clinical trial of PROSTVAC-VF — a poxvirus-based prostate cancer “vaccine” — in men with castration-resistant prostate cancer (CRPC). … READ MORE …
Filed under: Drugs in development | Tagged: castration-resistant prostate cancer, CRPC, immunobiologics, PROSTVAC-VF, vaccine | 14 Comments »
On Saturday there were two major prostate cancer sessions and additional poster sessions that included prostate cancer-related material at the annual meeting of the American Society for Clinical Oncology. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: MDV3100, OGX-011, PROSTVAC-VF, vaccines | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 